Abstract:This study investigates the regulatory role of DJ‐1 in the activation of astrocytes during cerebral ischemia/reperfusion (I/R) injury. It was discovered that DJ‐1 influences the transition of astrocytes to the neuroprotective A2 phenotype through the miR‐155/SHP‐1 signaling pathway, thereby mitigating I/R injury. Experiments using models in vivo and in vitro have confirmed the interaction between DJ‐1 and SHP‐1. These findings offer probable molecular targets for the treatment of ischemic stroke. Reactive astrocyte activation in the context of cerebral ischemia/reperfusion (I/R) injury gives rise to two distinct subtypes: the neurotoxic A1 type and the neuroprotective A2 type. DJ‐1 (Parkinson disease protein 7, PARK7), originally identified as a Parkinson's disease‐associated protein, is a multifunctional anti‐oxidative stress protein with molecular chaperone and signaling functions. SHP‐1 (Src homology 2 domain‐containing phosphatase‐1) is a protein tyrosine phosphatase closely associated with cellular signal transduction. miR‐155 is a microRNA that participates in cellular functions by regulating gene expression. Recent studies have uncovered the relationship between DJ‐1 and astrocyte‐mediated neuroprotection, which may be related to its antioxidant properties and regulation of signaling molecules such as SHP‐1. Furthermore, miR‐155 may exert its effects by influencing SHP‐1, providing a potential perspective for understanding the molecular mechanisms of stroke. A middle cerebral artery occlusion/reperfusion (MCAO/R) model and an oxygen–glucose deprivation/reperfusion (OGD/R) model were established to simulate focal cerebral I/R injury in vivo and in vitro, respectively. The in vivo interaction between DJ‐1 and SHP‐1 has been experimentally validated through immunoprecipitation. Overexpression of DJ‐1 attenuates I/R injury and suppresses miR‐155 expression. In addition, inhibition of miR‐155 upregulates SHP‐1 expression and modulates astrocyte activation phenotype. These findings suggest that DJ‐1 mediates astrocyte activation via the miR‐155/SHP‐1 pathway, playing a pivotal role in the pathogenesis of cerebral ischemia–reperfusion injury. Our results provide a potential way for exploring the pathogenesis of ischemic stroke and present promising targets for pharmacological intervention.

DJ-1 protein inhibits apoptosis in cerebral ischemia by regulating the Notch1 and Nrf2 signaling pathways

Attenuation of Inflammation by DJ-1 May Be a Drug Target for Cerebral Ischemia–Reperfusion Injury

DJ-1 Inhibits Ferroptosis in Cerebral Ischemia-Reperfusion Via ATF4/HSPA5 Pathway.

DJ-1 activates the Atg5-Atg12-Atg16L1 complex via Sirt1 to influence microglial polarization and alleviate cerebral ischemia/reperfusion-induced inflammatory injury

DJ‐1 regulates astrocyte activation through miR‐155/SHP‐1 signaling in cerebral ischemia/reperfusion injury

DJ-1 Alleviates Neuroinflammation and the Related Blood-Spinal Cord Barrier Destruction by Suppressing NLRP3 Inflammasome Activation via SOCS1/Rac1/ROS Pathway in a Rat Model of Traumatic Spinal Cord Injury

DJ-1 Regulates Microglial Polarization Through P62-Mediated TRAF6/IRF5 Signaling in Cerebral Ischemia-Reperfusion

SIRT1 Protects Against Apoptosis by Promoting Autophagy in the Oxygen Glucose Deprivation/Reperfusion-Induced Injury.

Stable overexpression of DJ-1 protects H9c2 cells against oxidative stress under a hypoxia condition.

Pretreatment with Sodium Phenylbutyrate Alleviates Cerebral Ischemia/Reperfusion Injury by Upregulating DJ-1 Protein

DJ-1 Deficiency in Hepatocytes Improves Liver Ischemia-Reperfusion Injury by Enhancing Mitophagy

Inhibition of the JAK2/STAT3 Pathway and Cell Cycle Re-Entry Contribute to the Protective Effect of Remote Ischemic Pre-Conditioning of Rat Hindlimbs on Cerebral Ischemia/reperfusion Injury.

DJ-1: Potential target for treatment of myocardial ischemia-reperfusion injury

Differential Regulation of NMDA Receptor Function by DJ‐1 and PINK1

Inhibitory Effect of Notch1 on Cell Apoptosis During Acute Phase of Focal Cerebral Ischemic Injury

DJ-1 Protects Retinal Pericytes Against High Glucose-Induced Oxidative Stress Through the Nrf2 Signaling Pathway

Involvement of Dj-1 in Ischemic Preconditioning-Induced Delayed Cardioprotection in Vivo

Protective effects of DJ-1 via antagonizing ROS-induced Beclin-1 up-regulation in hypoxia-reoxygenated HL-1 cardiomyocytes

DJ-1 activates the AMPK/mTOR pathway by binding RACK1 to induce autophagy and protect the myocardium from ischemia/hypoxia injury

Ischemic Postconditioning-Mediated DJ-1 Activation Mitigate Intestinal Mucosa Injury Induced by Myocardial Ischemia Reperfusion in Rats Through Keap1/Nrf2 Pathway

DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65